Privacy, Policy and Legal Issues > Public Policy Initiatives

September 8, 2022 - Today, the U.S. Food and Drug Administration issued a new safety alert for breast implants. The communication informed patients and providers about reports of squamous cell carcinoma (SCC) and various lymphomas located in the capsule or scar tissue around breast implants. These reports are different from BIA-ALCL, which the FDA previously alerted the public about.

Impact on Reproductive Services for People Facing Hereditary Cancers

FORCE is sharing the below statement in response to the U.S. Supreme Court’s ruling in Dobbs v. Jackson Women’s Health Organization as it relates to reproductive services for people facing hereditary cancers. 

"For 23 years, FORCE has championed access to evidence-based, quality healthcare, while supporting..."

Expand Medicare beneficiary access to genetic counseling, testing, cancer screening & prevention

Medicare covers genetic testing only for people already diagnosed with cancer, regardless of family history. For individuals with an inherited mutation causing increased cancer risk, coverage of many screenings and risk-reducing interventions is prohibited by law. This legislation will modify the Medicare statutes to allow coverage of these potentially life-saving services.

USPSTF Agrees to Develop National Recommendations 

December 17, 2021 – Today, FORCE was notified that the U.S. Preventive Services Task Force (USPSTF) has agreed to add Lynch syndrome-related cancers to its list of preventive services under consideration. This is a victory for the hereditary cancer community and individuals at increased risk of colorectal and related cancers!

Genetic counselors provide crucial information and expertise. But, did you know that these knowledgeable providers are not approved Medicare practitioners? The Access to Genetic Counselor Services Act (H.R. 2144/S. 1450) aims to remedy this issue. Join us in support of genetic counseling coverage for Medicare beneficiaries and expanded access to genetic counseling services for all Americans.

Oral chemotherapy has become the standard of care for many types of cancer. Importantly, most cancer therapies taken by mouth do not have IV or injected alternatives, and are the only option for some patients. Ask your lawmakers to support the Cancer Drug Coverage Parity Act, federal legislation that will ensure equal insurance coverage of cancer treatments regardless of how they are administered.

Take Action Now BECOME AN ADVOCATE 2022 Priorities Advocacy Archive

News Briefs

11/2/2022 - Asked congressional leaders to prioritize the Metastatic Breast Cancer Access to Care Act (H.R.3183 /S.1312), which eliminates the waiting periods for SSDI benefits and for Medicare coverage for individuals with metastatic breast cancer (MBC).

10/6/2022 - Endorsed the PSA for HIM Act (H.R. 1176), which would waive deductibles, copayments, and coinsurance for prostate cancer screenings for those with a family history or who are African-American.

9/13/2022 - Joined hundreds of health and patient orgs in a letter to Senate leaders, urging them to ensure access to telehealth services with passage of a two-year extension of current telehealth policies, while continuing to push for a permanent extension.

More


Sponsored By:

Genetech Merck